메뉴 건너뛰기




Volumn 35, Issue 6, 2012, Pages 933-937

The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus

Author keywords

Diarrhea; Dose optimization; Metformin; Risk factor; Type 2 diabetes mellitus

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN A1C; METFORMIN;

EID: 84861854715     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.933     Document Type: Article
Times cited : (38)

References (26)
  • 3
    • 60449089649 scopus 로고    scopus 로고
    • Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • American Diabetes Association European Association for Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32, 193-203 (2009).
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 5
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 346, 393-403 (2002).
    • (2002) N. Engl. J. Med. , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3    Hamman, R.F.4    Lachin, J.M.5    Walker, E.A.6    Nathan, D.M.7
  • 6
    • 17144389303 scopus 로고    scopus 로고
    • The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial
    • Diabetes Prevention Program Research Group
    • Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med., 142, 611-619 (2005).
    • (2005) Ann. Intern. Med. , vol.142 , pp. 611-619
    • Orchard, T.J.1    Temprosa, M.2    Goldberg, R.3    Haffner, S.4    Ratner, R.5    Marcovina, S.6    Fowler, S.7
  • 7
    • 80052838160 scopus 로고    scopus 로고
    • A systematic review of metformin to limit weight-gain with atypical antipsychotics
    • Lee YJ, Jeong JH. A systematic review of metformin to limit weight-gain with atypical antipsychotics. J. Clin. Pharm. Ther., 36, 537-545 (2011).
    • (2011) J. Clin. Pharm. Ther. , vol.36 , pp. 537-545
    • Lee, Y.J.1    Jeong, J.H.2
  • 8
    • 0031472452 scopus 로고    scopus 로고
    • Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
    • Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am. J. Med., 103, 491-497 (1997).
    • (1997) Am. J. Med. , vol.103 , pp. 491-497
    • Garber, A.J.1    Duncan, T.G.2    Goodman, A.M.3    Mills, D.J.4    Rohlf, J.L.5
  • 9
    • 23944491714 scopus 로고    scopus 로고
    • Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
    • Belcher G, Lambert C, Edwards G, Urquhart R, Matthews DR. Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes. Diabetes Res. Clin. Pract., 70, 53-62 (2005).
    • (2005) Diabetes Res. Clin. Pract. , vol.70 , pp. 53-62
    • Belcher, G.1    Lambert, C.2    Edwards, G.3    Urquhart, R.4    Matthews, D.R.5
  • 11
    • 81355132695 scopus 로고    scopus 로고
    • Evaluation of chronic diarrhea
    • Juckett G, Trivedi R. Evaluation of chronic diarrhea. Am. Fam. Physician, 84, 1119-1126 (2011).
    • (2011) Am. Fam. Physician , vol.84 , pp. 1119-1126
    • Juckett, G.1    Trivedi, R.2
  • 15
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41 (1976).
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 19
    • 70350075408 scopus 로고    scopus 로고
    • Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
    • Nies AT, Koepsell H, Winter S, Burk O, Klein K, Kerb R, Zanger UM, Keppler D, Schwab M, Schaeffeler E. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology, 50, 1227-1240 (2009).
    • (2009) Hepatology , vol.50 , pp. 1227-1240
    • Nies, A.T.1    Koepsell, H.2    Winter, S.3    Burk, O.4    Klein, K.5    Kerb, R.6    Zanger, U.M.7    Keppler, D.8    Schwab, M.9    Schaeffeler, E.10
  • 21
    • 0017653672 scopus 로고
    • Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides
    • Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabetologia, 13, 187-193 (1977).
    • (1977) Diabetologia , vol.13 , pp. 187-193
    • Caspary, W.F.1    Zavada, I.2    Reimold, W.3    Deuticke, U.4    Emrich, D.5    Willms, B.6
  • 22
    • 0031847175 scopus 로고    scopus 로고
    • Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus
    • Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet. Med., 15, 651-656 (1998).
    • (1998) Diabet. Med. , vol.15 , pp. 651-656
    • Scarpello, J.H.1    Hodgson, E.2    Howlett, H.C.3
  • 23
    • 78649908592 scopus 로고    scopus 로고
    • Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus
    • Cuthbertson J, Patterson S, O'Harte FP, Bell PM. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus. Metabolism, 60, 52-56 (2011).
    • (2011) Metabolism , vol.60 , pp. 52-56
    • Cuthbertson, J.1    Patterson, S.2    O'Harte, F.P.3    Bell, P.M.4
  • 24
    • 77955573674 scopus 로고    scopus 로고
    • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): A randomised trial
    • DURATION-2 Study Group
    • Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE, DURATION-2 Study Group. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet, 376, 431-439 (2010).
    • (2010) Lancet , vol.376 , pp. 431-439
    • Bergenstal, R.M.1    Wysham, C.2    Macconell, L.3    Malloy, J.4    Walsh, B.5    Yan, P.6    Wilhelm, K.7    Malone, J.8    Porter, L.E.9
  • 25
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368, 1696-1705 (2006).
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 26
    • 0030443768 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus
    • Sambol NC, Chiang J, O'Conner M, Liu CY, Lin ET, Goodman AM, Benet LZ, Karam JH. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus. J. Clin. Pharmacol., 36, 1012-1021 (1996).
    • (1996) J. Clin. Pharmacol. , vol.36 , pp. 1012-1021
    • Sambol, N.C.1    Chiang, J.2    O'Conner, M.3    Liu, C.Y.4    Lin, E.T.5    Goodman, A.M.6    Benet, L.Z.7    Karam, J.H.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.